Phase 1 clinical trial data published this week in the journal Clinical Cancer Research show early promise of the investigational anti-cancer agent tucatinib (formerly ONT-380) against HER2+ breast cancer. The 50 women treated ...
Jan 11, 2017
0
1
Scientists cannot be expected to drop everything they're working on to turn their attention to beating COVID-19, according to the winner of the 2019 Nobel Prize in Physiology or Medicine, Professor Sir Peter Ratcliffe.
Oct 23, 2020
0
1
When cells suffer too much DNA damage, they are usually forced to undergo programmed cell death, or apoptosis. However, cancer cells often ignore these signals, flourishing even after chemotherapy drugs have ravaged their ...
May 14, 2013
0
0
A variant typical of the Finnish population that protects against heart diseases was identified in the FinnGen genomic study coordinated by the University of Helsinki. The risk of developing heart diseases is roughly one-fifth ...
Aug 17, 2022
0
44
(Medical Xpress) -- Frequent use of energy drinks is associated with binge drinking, alcohol-related social problems and misuse of prescription drugs among musicians, according to researchers at the University at Buffalo's ...
Jun 16, 2011
0
0
Researchers at the USC Viterbi School of Engineering have designed a new drug cocktail that kills some types of brain and soft tissue cancers by tricking the cancer cells to behave as if they were starving for their favorite ...
Feb 20, 2020
0
13
Sodium–glucose cotransporter 2 (SGLT2) inhibitors, such as empagliflozin, dapagliflozin, canagliflozin and ertugliflozin, have been game changers in the treatment of type 2 diabetes, but their potential for closing the ...
Jul 25, 2022
0
28
According to a study, type 1 diabetes could be prevented by inhibiting a gene associated with the onset of the disease. A drug based on the same mechanism has already been approved for the treatment of another autoimmune ...
Nov 9, 2022
0
71
Withanolides, a class of naturally occurring compounds found in plants, have long been a focus of cancer research due to their ability to inhibit cancer cell growth, induce cell death and prevent metastasis. These compounds ...
Jun 28, 2024
0
36
A study led by the University of Southampton, funded by Cancer Research UK, has shown a new drug—originally developed to tackle the scarring of organ tissue—could help to significantly improve the success rate of cancer ...
Mar 2, 2020
0
101
